# BETAMETHASONE DIPROPIONATE
> **ANDA215847** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2022-04-12
## Drug
- **FDA Application Number:** ANDA215847
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BETAMETHASONE DIPROPIONATE
- **Generic name:** BETAMETHASONE DIPROPIONATE
- **Active ingredients:** BETAMETHASONE DIPROPIONATE
- **Dosage form:** OINTMENT
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** PADAGIS ISRAEL
- **Manufacturer:** Padagis Israel Pharmaceuticals Ltd
- **First approval:** 2022-04-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215847)
---
*MORVS · CC0 1.0*